Profil
Laura Mondano worked as a Director of Global Regulatory Affairs at Genzyme Corp.
and as a Manager of Regulatory Affairs at both Boston Scientific Corp.
and Anika Therapeutics, Inc. She then served as the Vice President of Regulatory and Quality at Histogenics Corp.
from 2012 to 2016, and as the Vice President of Regulatory Affairs at Harvard Apparatus Regenerative Technology, Inc. Ms. Mondano received her undergraduate degree from the University of New Hampshire.
Anciens postes connus de Laura Mondano
| Sociétés | Poste | Fin |
|---|---|---|
| OCUGEN, INC. | Conseiller Juridique Général | 01/02/2016 |
| ANIKA THERAPEUTICS, INC. | Conseiller Juridique Général | - |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Conseiller Juridique Général | - |
| BOSTON SCIENTIFIC CORPORATION | Conseiller Juridique Général | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Conseiller Juridique Général | - |
Formation de Laura Mondano
| University of New Hampshire | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |